Endocannabinoids modulate apoptosis in endometriosis and adenomyosis
article
OA: closed
CC0
⤵ 33 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated how endocannabinoids influence the process of apoptosis in women with endometriosis and adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (50)
- [Administration of MICRONIZED PALMITOYLETHANOLAMIDE (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results.] via openalex
- Apoptosis in Endometriosis via openalex
- Coexistence of adenomyosis and endometrioid endometrial cancer: Role in surgical guidance and prognosis estimation via openalex
- Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis via openalex
- Diagnosis and treatment of rectovaginal endometriosis: an overview via openalex
- Economic burden of endometriosis via openalex
- Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)–transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study via openalex
- Effect of palmitoylethanolamide–polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations via openalex
- Elevated immunoreactivity of RANTES and CCR1 correlate with the severity of stages and dysmenorrhea in women with deep infiltrating endometriosis via openalex
- Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis via openalex
- Endocannabinoid involvement in endometriosis via openalex
- Endometriomas are more frequent on the left side via openalex
- Endometriosis-associated Malignancy via openalex
- Fas and Fas-Ligand in Eutopic and Ectopic Endometrium of Women With Endometriosis: The Possible Immune Privilege of Ectopic Endometrium via openalex
- Increased steroid receptor RNA activator protein (SRAP) accompanied by decreased estrogen receptor-beta (ER-β) levels during the malignant transformation of endometriosis associated ovarian clear cell carcinoma via openalex
- Pigment epithelial-derived factor expression in endometriotic lesions in a rat model of endometriosis via openalex
- Potential influence of in utero and early neonatal exposures on the later development of endometriosis via openalex
- Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via openalex
- The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain via openalex
- The Effects and Possible Mechanisms of Puerarin to Treat Endometriosis Model Rats via openalex
- The molecular connections between the cannabinoid system and endometriosis via openalex
- W2033362135 via openalex
- W2040768464 via openalex
- W2044927265 via openalex
- W2046867627 via openalex
- W2049230776 via openalex
- W2052646320 via openalex
- W2055278558 via openalex
- W2058418915 via openalex
- W2015401786 via openalex
- W2074556435 via openalex
- W2010575863 via openalex
- W2081786271 via openalex
- W2082084857 via openalex
- W2095337103 via openalex
- W1994321149 via openalex
- W2125516369 via openalex
- W2126371827 via openalex
- W2139773756 via openalex
- W2162323973 via openalex
- W1976277327 via openalex
- W1964852501 via openalex
- W2261860681 via openalex
- W2283050282 via openalex
- W1580448035 via openalex
- W1557215935 via openalex
- W2020914269 via openalex
- W1487132128 via openalex
- W2030864103 via openalex
- W2031212289 via openalex
Cited by (33)
- N-acetylcysteine stimulates organelle malfunction in endometriotic cells via IFN-gamma signaling 2025
- Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2024
- Endometriosis: A Comprehensive Analysis of the Pathophysiology, Treatment, and Nutritional Aspects, and Its Repercussions on the Quality of Life of Patients 2024
- Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2024
- Endometrial Cell-Type Specific Regulation of the Endocannabinoids System and the Impact of Menstrual Cycle and Endometriosis 2024
- Reviewer #2 (Public Review): Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2024
- Reviewer #1 (Public Review): Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2024
- Author response: Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2024
- eLife Assessment: Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2024
- Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2024
- Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2024
- Endometrial cell‑derived exosomes facilitate the development of adenomyosis via the IL‑6/JAK2/STAT3 pathway 2023
- Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System 2023
- Cannabis and Endometriosis: The roles of the gut microbiota and the<br aria-hidden="true" />endocannabinoid system 2023
- Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2023
- Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model 2023
- Endometriosis: Features and potential role of medicinal cannabis 2023
- Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response 2023
- Research progress on the beneficial effects of exercise on endocrine system-related diseases in women by regulating ER stress pathways 2023
- Cannabis for endometriosis‐related pain and symptoms: It's high time that we see this as a legitimate treatment 2023
- Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System 2023
- Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications 2022
- Cannabinoids and chronic pelvic pain in women: Focus on endometriosis 2021
- Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms 2021
- Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms. 2021
- N-Acyl Dopamines Induce Apoptosis in Endometrial Stromal Cells from Patients with Endometriosis 2021
- Implications of dysregulated endogenous cannabinoid family members in the pathophysiology of endometriosis 2021
- Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain 2021
- Neurogenic Inflammation in the Context of Endometriosis—What Do We Know? 2021
- Phytochemical characteristics from Phaleria macrocarpa and its inhibitory activity on the peritoneal damage of endometriosis 2020
- Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey 2019
- Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis 2019
- Association of Endometriosis and Adenomyosis: Vast Literature but Scant Conclusive Data 2018
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:20:25.745717+00:00
License: CC0
· commercial use OK